|
|
||||||||
We initiated a longitudinal study of Bancroftian filariasis to improve understanding of dynamics and risk factors for infection in villages near Cairo, Egypt. Baseline prevalence rates for microfilaremia and filarial antigenemia for 1,853 subjects more than 9 years of age were 7.7% and 11.2%, respectively. Microfilaria counts, antigen levels, and microfilaremia incidence over a 1-year period were all significantly lower in older people. These findings suggest that humans develop partial immunity to Wuchereria bancrofti over time. One-year incidence rates for microfilaremia and antigenemia were 1.8% and 3.1%, respectively. Filarial antigenemia, IgG4 antibody to recombinant antigen BmM14, and household infection were all significant risk factors for microfilaremia incidence. Microfilaria counts and parasite antigen levels were significantly reduced by diethylcarbamazine therapy, but many infected subjects refused treatment, and most treated people were still infected one year later. Incident infections approximately balanced infections lost to produce an apparent state of dynamic equilibrium.
This article has been cited by other articles:
![]() |
H. A. Farid, Z. S. Morsy, H. Helmy, R. M. R. Ramzy, M. El Setouhy, and G. J. Weil A Critical Appraisal of Molecular Xenomonitoring as a Tool for Assessing Progress toward Elimination of Lymphatic Filariasis Am J Trop Med Hyg, October 1, 2007; 77(4): 593 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. FARID, R. E. HAMMAD, M. M. HASSAN, R. M. R. RAMZY, M. EL SETOUHY, and G. J. WEIL EFFECTS OF COMBINED DIETHYLCARBAMAZINE AND ALBENDAZOLE TREATMENT OF BANCROFTIAN FILARIASIS ON PARASITE UPTAKE AND DEVELOPMENT IN CULEX PIPIENS L. Am J Trop Med Hyg, July 1, 2005; 73(1): 108 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lammie 2. RESEARCH DIRECTLY LINKED WITH GPELF ACTIVITIES (OPERATIONAL RESEARCH): 2.1 ESSENTIAL TOOLS--DIAGNOSTICS Am J Trop Med Hyg, November 1, 2004; 71(5_suppl): 3 - 6. [Full Text] [PDF] |
||||
![]() |
M. EL SETOUHY, R. M. R. RAMZY, E. S. AHMED, A. M. KANDIL, O. HUSSAIN, H. A. FARID, H. HELMY, and G. J. WEIL A RANDOMIZED CLINICAL TRIAL COMPARING SINGLE- AND MULTI-DOSE COMBINATION THERAPY WITH DIETHYLCARBAMAZINE AND ALBENDAZOLE FOR TREATMENT OF BANCROFTIAN FILARIASIS Am J Trop Med Hyg, February 1, 2004; 70(2): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. WEERASOORIYA, M. ITOH, M. Z. ISLAM, X.-G. QIU, Y. FUJIMAKI, and E. KIMURA PREVALENCE AND LEVELS OF FILARIA-SPECIFIC URINARY IgG4 AMONG CHILDREN LESS THAN FIVE YEARS OF AGE AND THE ASSOCIATION OFANTIBODY POSITIVITY BETWEEN CHILDREN AND THEIR MOTHERS Am J Trop Med Hyg, April 1, 2003; 68(4): 465 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. FARID, R. E. HAMMAD, D. A. SOLIMAN, M. A. EL SETOUHY, R. M. R. RAMZY, and G. J. WEIL RELATIONSHIPS BETWEEN WUCHERERIA BANCROFTI MICROFILARIA COUNTS IN HUMAN BLOOD AND PARASITE UPTAKE AND MATURATION IN CULEX PIPIENS, WITH OBSERVATIONS ON THE EFFECTS OF DIETHYLCARBAMAZINE TREATMENT ON THESE PARAMETERS Am J Trop Med Hyg, March 1, 2003; 68(3): 286 - 293. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |